GlassScriptPhysician profile
Kathryn E Mcintosh
NPI 1942711528
$4,440.93
in general payments reported to CMS, 2019-2025
24 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.40 · 2022: $775 · 2023: $1,316 · 2024: $1,269 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,228 · Education: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,227.94 |
| Education | $409.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,060.37 | 2022-2025 | Fasenra, Tezspire, Breztri |
| Jazz Pharmaceuticals INC. | $920.69 | 2022-2025 | |
| Amgen INC. | $279.72 | 2022-2024 | Tezspire, Tavneos |
| Glaxosmithkline, LLC. | $260.50 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $256.72 | 2022-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.14 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Inspire Medical Systems, INC. | $225.78 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $221.16 | 2022-2025 | |
| Grifols USA, LLC | $171.75 | 2022-2025 | Prolastin-C Liquid |
| Astellas Pharma US INC | $149.99 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $135.84 | 2024-2025 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $108.84 | 2023-2025 | Glassia |
| Verona Pharma, INC. | $98.82 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $57.94 | 2025 | Sunosi |
| Pulmonx Corporation | $41.52 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $35.43 | 2024 | Grastek, Ragwitek, Odactra |
| Novartis Pharmaceuticals Corporation | $28.40 | 2021 | |
| Fisher & Paykel Healthcare INC | $28.16 | 2023 | Fisher & Paykel Healthcare |
| Mylan Specialty L.P. | $24.66 | 2024 | Yupelri |
| Philips North America LLC | $21.72 | 2023 | |
| Viatris Specialty LLC | $21.58 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $20.75 | 2023 | |
| Genzyme Corporation | $18.67 | 2024 | |
| Inogen, INC. | $13.78 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.